Difference between revisions of "TG004692"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
|nrt=155.006 | |nrt=155.006 | ||
|ntransition=9 | |ntransition=9 | ||
| − | |pepnrt=use (+0. | + | |pepnrt=use (+0.381) |
|peptide=PE001754 | |peptide=PE001754 | ||
|prt=75.178 | |prt=75.178 | ||
Latest revision as of 17:41, 23 May 2021
| Peptide | K.TFLDKFNHEAEDLFYQSSLASWNYNTN[H5N4FS]ITEENVQNMNNAGDKWSAFLK.E (PE001754) |
|---|---|
| Sequence | TFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLK |
| Glycans(s) | H5N4FS (N27) |
| Mod(s) | |
| Molecular Weight | 7,721.341 |
| Charge | 6+ |
| Protein | ACE2 (Q9BYF1) |
| Spectrum File | MS_50_ACE2_Trypsin_2 |
| Method | Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS |
| Analytical Fraction | No enrichment |
| Sample | Human ACE2 Protein |
Transitions
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Prod. m/z | Prod. z | Label | %Int |
|---|---|---|---|---|---|---|---|---|
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,462.677 | 4+ | Y[pN] | 44.0 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,634.986 | 4+ | Y[pH3N2] | 11.0 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,170.343 | 5+ | Y[pN] | 9.6 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,499.191 | 4+ | Y[pNF]* | 7.3 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,411.907 | 4+ | Y[p] | 7.2 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,513.446 | 4+ | Y[pN2] | 6.3 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,553.960 | 4+ | Y[pHN2] | 6.1 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,671.500 | 4+ | Y[pH3N2F]* | 5.5 |
| 75.087 | 75.178 | 155.006 | 1,284.896 | 6+ | 1,630.987 | 4+ | Y[pH2N2F]* | 5.3 |
Spectra
15868;EThcD;75.495;15863;1285.069;Byonic:q-value=0.00202/GPS:MinICScore=122.340
15870;HCD;75.503;15863;1285.069;